Author:
Lu Hongzhou,Ai Jingwen,Shen Yinzhong,Li Yang,Li Tao,Zhou Xian,Zhang Haocheng,Zhang Qiran,Ling Yun,Wang Sheng,Qu Hongping,Gao Yuan,Li Yingchuan,Yu Kanglong,Zhu Duming,Zhu Hecheng,Tian Rui,Zeng Mei,Li Qiang,Song Yuanlin,Li Xiangyang,Xu Jinfu,Xu Jie,Mao Enqiang,Hu Bijie,Li Xin,Zhu Lei,Zhang Wenhong
Abstract
AbstractObjectiveTo describe and evaluate the impact of diseases control and prevention on epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai.DesignA retrospective descriptive studySettingChinaParticipantsEpidemiology information was collected from publicly accessible database. 265 patients admitted to Shanghai Public Health Center with confirmed COVID-19 were enrolled for clinical features analysis.Main outcome measurePrevention and control measures taken by Shanghai government, epidemiological, demographic, clinical, laboratory and radiology data were collected. Weibull distribution, Chi-square test, Fisher’s exact test, t test or Mann-Whitney U test were used in statistical analysis.ResultsCOVID-19 transmission rate within Shanghai had reduced over 99% than previous speculated, and the exponential growth has been stopped so far. Epidemic was characterized by the first stage mainly composed of imported cases and the second stage where >50% of cases were local. The incubation period was 6.4 (95% CI 5.3 to 7.6) days and the mean onset-admission interval was 5.5 days (95% CI, 5.1 to 5.9). Median time for COVID-19 progressed to severe diseases were 8.5 days (IQR: 4.8-11.0 days). By February 11th, proportion of patients being mild, moderate, severe and critically ill were 1.9%(5/265), 89.8%(238/265), 3.8%(10/265), 4.5%(12/265), respectively; 47 people in our cohort were discharged, and 1 patient died.ConclusionStrict controlling of the transmission rate at the early stage of an epidemic in metropolis can quickly prohibit the spread of the diseases. Controlling local clusters is the key to prevent outbreaks from imported cases. Most COVID-19 severe cases progressed within 14 days of disease onset. Multiple systemic laboratory abnormalities had been observed before significant respiratory dysfunction.
Publisher
Cold Spring Harbor Laboratory
Reference17 articles.
1. J. C. Chinese researchers reveal draft genome of virus implicated in Wuhan pneumonia outbreak. In. Washington, DC: American Association for the Advancement of Science https://www.sciencemag.org/news/2020/01/chinese-researchers-reveal-draft-genome-virus-implicated-wuhan-pneumonia-outbreak.
2. A Novel Coronavirus from Patients with Pneumonia in China, 2019
3. WHO names deadly virus from China as ‘COVID-19’. In. https://guardian.ng/news/who-names-deadly-virus-from-china-as-covid-19/.
4. Holshue ML , DeBolt C , Lindquist S , et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020:10.1056/NEJMoa2001191.
5. The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献